Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial

IMPORTANCE: Current therapies for traumatic blood loss focus on hemorrhage control and blood volume replacement. Severe hemorrhagic shock, however, is associated with a state of arginine vasopressin (AVP) deficiency, and supplementation of this hormone may decrease the need for blood products in res...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Surg
Autors principals: Sims, Carrie A., Holena, Daniel, Kim, Patrick, Pascual, Jose, Smith, Brian, Martin, Neils, Seamon, Mark, Shiroff, Adam, Raza, Shariq, Kaplan, Lewis, Grill, Elena, Zimmerman, Nicole, Mason, Christopher, Abella, Benjamin, Reilly, Patrick
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2019
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6714462/
https://ncbi.nlm.nih.gov/pubmed/31461138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamasurg.2019.2884
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars